Free Trial

Sanuwave Health (SNWV) Competitors

Sanuwave Health logo
$31.72 -0.51 (-1.58%)
As of 07/2/2025 04:00 PM Eastern

SNWV vs. FNA, LQDA, BLFS, PLSE, KMTS, INMD, MDXG, IRMD, SIBN, and CBLL

Should you be buying Sanuwave Health stock or one of its competitors? The main competitors of Sanuwave Health include Paragon 28 (FNA), Liquidia Technologies (LQDA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Kestra Medical Technologies (KMTS), InMode (INMD), MiMedx Group (MDXG), iRadimed (IRMD), SiBone (SIBN), and CeriBell (CBLL). These companies are all part of the "medical equipment" industry.

Sanuwave Health vs. Its Competitors

Sanuwave Health (NASDAQ:SNWV) and Paragon 28 (NYSE:FNA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Sanuwave Health has higher earnings, but lower revenue than Paragon 28. Paragon 28 is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanuwave Health$32.63M8.32-$31.37M-$4.56-6.96
Paragon 28$256.18M4.29-$57.53M-$0.63-20.80

Sanuwave Health has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500. Comparatively, Paragon 28 has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500.

Paragon 28 has a consensus price target of $12.75, indicating a potential downside of 2.71%. Given Paragon 28's stronger consensus rating and higher possible upside, analysts plainly believe Paragon 28 is more favorable than Sanuwave Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanuwave Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Paragon 28
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20

Paragon 28 has a net margin of -25.31% compared to Sanuwave Health's net margin of -89.86%. Sanuwave Health's return on equity of 0.00% beat Paragon 28's return on equity.

Company Net Margins Return on Equity Return on Assets
Sanuwave Health-89.86% N/A -145.76%
Paragon 28 -25.31%-37.90%-18.22%

In the previous week, Paragon 28 had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 1 mentions for Paragon 28 and 0 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 1.87 beat Paragon 28's score of 0.59 indicating that Sanuwave Health is being referred to more favorably in the media.

Company Overall Sentiment
Sanuwave Health Very Positive
Paragon 28 Positive

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 63.6% of Paragon 28 shares are owned by institutional investors. 36.6% of Sanuwave Health shares are owned by company insiders. Comparatively, 15.3% of Paragon 28 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Paragon 28 beats Sanuwave Health on 10 of the 16 factors compared between the two stocks.

Get Sanuwave Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNWV vs. The Competition

MetricSanuwave HealthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$275.75M$10.49B$5.54B$8.87B
Dividend YieldN/A2.09%5.39%4.10%
P/E Ratio-6.9616.6626.2319.90
Price / Sales8.3229.93413.23113.66
Price / CashN/A22.7836.1356.90
Price / Book-21.293.648.045.38
Net Income-$31.37M$233.36M$3.15B$248.50M
7 Day Performance-4.00%1.00%1.44%2.04%
1 Month Performance12.01%3.01%3.62%4.84%
1 Year PerformanceN/A-11.64%34.68%20.23%

Sanuwave Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNWV
Sanuwave Health
N/A$31.72
-1.6%
N/AN/A$275.75M$32.63M-6.9640Positive News
FNA
Paragon 28
0.4926 of 5 stars
$13.11
+0.1%
$12.75
-2.7%
+98.0%$1.10B$256.18M-17.71343,000High Trading Volume
LQDA
Liquidia Technologies
3.3832 of 5 stars
$13.10
+2.1%
$26.89
+105.3%
+1.9%$1.10B$14M-8.2950
BLFS
BioLife Solutions
3.0974 of 5 stars
$21.49
+0.0%
$31.17
+45.0%
+12.5%$1.02B$82.25M-74.10440Positive News
High Trading Volume
PLSE
Pulse Biosciences
1.375 of 5 stars
$15.08
+1.3%
N/A+34.3%$1.00B$700K0.00140Positive News
KMTS
Kestra Medical Technologies
N/A$17.67
-1.3%
$27.50
+55.6%
N/A$919.14MN/A0.00300High Trading Volume
INMD
InMode
3.3451 of 5 stars
$14.19
+0.9%
$18.54
+30.7%
-12.6%$889.35M$394.82M6.09480High Trading Volume
MDXG
MiMedx Group
3.7568 of 5 stars
$5.94
flat
$12.50
+110.4%
-8.1%$877.35M$348.88M22.00870High Trading Volume
IRMD
iRadimed
4.6921 of 5 stars
$60.84
+0.2%
$72.00
+18.3%
+40.9%$771.93M$73.24M39.25110Positive News
High Trading Volume
SIBN
SiBone
4.1648 of 5 stars
$18.43
+1.9%
$22.50
+22.1%
+41.8%$770.90M$167.18M-28.80350High Trading Volume
CBLL
CeriBell
2.6026 of 5 stars
$18.90
-2.0%
$32.14
+70.1%
N/A$697.20M$65.44M0.00N/AHigh Trading Volume

Related Companies and Tools


This page (NASDAQ:SNWV) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners